SG Americas Securities »

Arrowhead Pharmaceuticals In Note 1/1 shares owned by SG Americas Securities

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals In Note 1/1 shares owned by SG Americas Securities from 13F filings

Historical chart of SG Americas Securities investment in Arrowhead Pharmaceuticals In Note 1/1

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals In Note 1/1 held by SG Americas Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals In Note 1/1 by SG Americas Securities

Quarter filed Position value Share count Share price at filing
2026-03-31 $715k 6.9k 103.62

More positions owned by SG Americas Securities

Broadcom (AVGO)
Alphabet Inc Class A cs (GOOGL)
JPMorgan Chase & Co. (JPM)
Micron Technology (MU)
Facebook Inc cl a (META)
Alphabet Inc Class C cs (GOOG)
Microsoft Corporation (MSFT)
Apple (AAPL)
Spdr S&p 500 Etf (SPY)
Linde (LIN)
Johnson & Johnson (JNJ)
Equinix (EQIX)
Costco Wholesale Corporation (COST)
Lumentum Hldgs Opt Call Option
Pinduoduo (PDD)

View all positions for SG Americas Securities

Top funds holding Arrowhead Pharmaceuticals In Note 1/1

Deerfield Management Company
Linden Advisors
Camden Asset Management
LMR Partners
Readystate Asset Management
Calamos Advisors
Jump Financial
Context Capital Management
Bnp Paribas Arbitrage, Snc
State Street Corporation
Oaktree Capital Management
Polar Securities
Lazard Asset Management
Shenkman Capital Management
Point72 Asset Management

View all funds holding Arrowhead Pharmaceuticals In Note 1/1